{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:44:35Z","timestamp":1789789475944,"version":"4.0.1"},"reference-count":149,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>The increasing global burden of liver disease leads to more frequent encounters of anesthesiologists with these high-risk patients. This review summarizes current evidence on perioperative management of patients with liver disease, acute liver failure, and acute-on-chronic liver failure undergoing surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>The etiology of liver disease is evolving with metabolic dysfunction on the rise creating new perioperative challenges. Patients with liver disease are particularly at risk of cardiovascular events, impaired glucose regulation, and delayed anesthetic recovery. Conventional coagulation assays inadequately reflect bleeding risk in patients with liver disease, whereas viscoelastic-guided coagulation strategies are associated with reduced transfusion requirements. Overall, 90-day mortality is about five-fold higher in patients with liver cirrhosis compared with the general population. Risk scores and clinical assessments are necessary to balance patient- and procedure-related risks during preoperative evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Patients with liver disease undergoing surgery constitute one of the highest-risk surgical populations. Systematic preoperative assessment, individualized anesthetic drug selection, viscoelastic-guided coagulation management, and early multidisciplinary involvement are essential to improve outcomes. High-quality prospective evidence to guide anesthetic practice in patients with liver disease is urgently needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aco.0000000000001648","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:02:35Z","timestamp":1774526555000},"page":"390-400","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Liver disease and general anesthesia: what the anesthesiologist needs to know"],"prefix":"10.1097","volume":"39","author":[{"given":"Moritz","family":"Flick","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcial","family":"Sebode","sequence":"additional","affiliation":[{"name":"I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Eichlseder","sequence":"additional","affiliation":[{"name":"Division of Anaesthesiology and Intensive Care 1, Department of Anaesthesiology and Intensive Care, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Saugel","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine"},{"name":"Outcomes Research Consortium, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"R1-20260429","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bjae.2021.11.006","article-title":"Perioperative management of patients with liver disease.","volume":"22","author":"Gilbert-Kawai","year":"2022","journal-title":"BJA Educ"},{"key":"R2-20260429","first-page":"103397","article-title":"Perioperative management of patients with liver disease for non-hepatic surgery: a systematic review.","volume":"75","author":"Endale Simegn","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"key":"R3-20260429","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis.","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"key":"R4-20260429","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jhep.2012.03.037","article-title":"Assessment of risk for non-hepatic surgery in cirrhotic patients.","volume":"57","author":"Bhangui","year":"2012","journal-title":"J Hepatol"},{"key":"R5-20260429","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.3748\/wjg.v13.i30.4056","article-title":"Outcomes of patients with cirrhosis undergoing non-hepatic surgery: risk assessment and management.","volume":"13","author":"Millwala","year":"2007","journal-title":"World J Gastroenterol"},{"key":"R6-20260429","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/life13010132","article-title":"Clinical guideline on perioperative management of patients with advanced chronic liver disease.","volume":"13","author":"Canillas","year":"2023","journal-title":"Life"},{"key":"R7-20260429","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update.","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"R8-20260429","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bjae.2022.05.002","article-title":"Perioperative management for hepatic resection surgery.","volume":"22","author":"Patel","year":"2022","journal-title":"BJA Educ"},{"key":"R9-20260429","first-page":"226","article-title":"Anaesthesia management for liver transplantation: a narrative review.","volume":"34","author":"Cekmen","year":"2024","journal-title":"J Perioper Pract"},{"key":"R10-20260429","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","article-title":"Pathogenesis of liver cirrhosis.","volume":"20","author":"Zhou","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R11-20260429","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/hep.27388","article-title":"Emerging trends in hepatocellular carcinoma incidence and mortality.","volume":"61","author":"Njei","year":"2015","journal-title":"Hepatology"},{"key":"R12-20260429","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1056\/NEJMcibr2106594","article-title":"Hepatocellular carcinoma - Origins and outcomes.","volume":"385","author":"Kelley","year":"2021","journal-title":"N Engl J Med"},{"key":"R13-20260429","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0140-6736(25)01917-8","article-title":"Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.","volume":"406","author":"Naghavi","year":"2025","journal-title":"Lancet"},{"key":"R14-20260429","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/HEP.0000000000000671","article-title":"AASLD Practice Guidance on Acute-on-chronic liver failure and the management of critically ill patients with cirrhosis.","volume":"79","author":"Karvellas","year":"2024","journal-title":"Hepatology"},{"key":"R15-20260429","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMra2207599","article-title":"Alcohol-associated hepatitis.","volume":"387","author":"Bataller","year":"2022","journal-title":"N Engl J Med"},{"key":"R16-20260429","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra2412865","article-title":"Metabolic dysfunction-associated steatotic liver disease.","volume":"393","author":"Targher","year":"2025","journal-title":"N Engl J Med"},{"key":"R17-20260429","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-024-02072-z","article-title":"Liver diseases: epidemiology, causes, trends and predictions.","volume":"10","author":"Gan","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"R18-20260429","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/jpm14020132","article-title":"Prevention in hepatology.","volume":"14","author":"Munoz-Restrepo","year":"2024","journal-title":"J Pers Med"},{"key":"R19-20260429","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/obr.12407","article-title":"Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies.","volume":"17","author":"Li","year":"2016","journal-title":"Obes Rev"},{"key":"R20-20260429","doi-asserted-by":"crossref","first-page":"105110","DOI":"10.1016\/j.ebiom.2024.105110","article-title":"Sedentary lifestyle, physical activity, and gastrointestinal diseases: evidence from Mendelian randomization analysis.","volume":"103","author":"Chen","year":"2024","journal-title":"EBioMedicine"},{"key":"R21-20260429","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1136\/gutjnl-2023-330110","article-title":"Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis.","volume":"72","author":"En Li Cho","year":"2023","journal-title":"Gut"},{"key":"R22-20260429","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jhep.2022.11.010","article-title":"A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes.","volume":"78","author":"Ajmera","year":"2023","journal-title":"J Hepatol"},{"key":"R23-20260429","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3390\/life15050779","article-title":"Innovative strategies in the diagnosis and treatment of liver cirrhosis and associated syndromes.","volume":"15","author":"Sah","year":"2025","journal-title":"Life"},{"key":"R24-20260429","first-page":"e49920","article-title":"Diagnosis and treatment of liver disease: current trends and future directions.","volume":"15","author":"Wazir","year":"2023","journal-title":"Cureus"},{"key":"R25-20260429","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis.","volume":"392","author":"Sanyal","year":"2025","journal-title":"N Engl J Med"},{"key":"R26-20260429","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis.","volume":"391","author":"Loomba","year":"2024","journal-title":"N Engl J Med"},{"key":"R27-20260429","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis.","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"key":"R28-20260429","first-page":"171","article-title":"Critical care considerations in the management of acute-on-chronic liver failure.","volume":"26","author":"MacDonald","year":"2020","journal-title":"Curr Opin Crit Care"},{"key":"R29-20260429","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00134-023-07149-x","article-title":"Intensive care management of acute-on-chronic liver failure.","volume":"49","author":"Perricone","year":"2023","journal-title":"Intensive Care Med"},{"key":"R30-20260429","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/aor.14915","article-title":"Extracorporeal liver support systems in patients with acute-on-chronic liver failure: an updated systematic review and meta-analysis.","volume":"49","author":"Liu","year":"2025","journal-title":"Artif Organs"},{"key":"R31-20260429","first-page":"e1199","article-title":"Artificial liver support systems in acute liver failure and acute-on-chronic liver failure: systematic review and meta-analysis.","volume":"7","author":"Brown","year":"2025","journal-title":"Crit Care Explor"},{"key":"R32-20260429","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2024.07.032","article-title":"EASL Clinical Practice Guidelines on liver transplantation.","volume":"81","author":"Samuel","year":"2024","journal-title":"J Hepatol"},{"key":"R33-20260429","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S2468-1253(23)00321-7","article-title":"Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update.","volume":"9","author":"Cooke","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R34-20260429","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1056\/NEJMra0801644","article-title":"Hepatitis B virus infection.","volume":"359","author":"Dienstag","year":"2008","journal-title":"N Engl J Med"},{"key":"R35-20260429","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra2211764","article-title":"New Approaches to chronic hepatitis B.","volume":"388","author":"Dusheiko","year":"2023","journal-title":"N Engl J Med"},{"key":"R36-20260429","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMcp1006613","article-title":"Clinical practice. Chronic hepatitis C infection.","volume":"364","author":"Rosen","year":"2011","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"R37-20260429","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/liv.13673","article-title":"Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?","volume":"38","author":"Asselah","year":"2018","journal-title":"Liver Int"},{"key":"R38-20260429","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jhep.2019.05.011","article-title":"Hepatitis A and E: differences and commonalities.","volume":"72","author":"Gotlieb","year":"2020","journal-title":"J Hepatol"},{"key":"R39-20260429","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1034\/j.1399-6576.2003.00154.x","article-title":"What anaesthetists need to know about viral hepatitis.","volume":"47","author":"Lentschener","year":"2003","journal-title":"Acta Anaesthesiol Scand"},{"key":"R40-20260429","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury.","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"R41-20260429","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJMra1816149","article-title":"Drug-induced liver injury - types and phenotypes.","volume":"381","author":"Hoofnagle","year":"2019","journal-title":"N Engl J Med"},{"key":"R42-20260429","doi-asserted-by":"crossref","first-page":"100737","DOI":"10.1016\/j.curtheres.2024.100737","article-title":"Biomarkers of hepatic toxicity: an overview.","volume":"100","author":"Thakur","year":"2024","journal-title":"Curr Ther Res Clin Exp"},{"key":"R43-20260429","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4254\/wjh.v12.i4.125","article-title":"Liver injury induced by paracetamol and challenges associated with intentional and unintentional use.","volume":"12","author":"Rotundo","year":"2020","journal-title":"World J Hepatol"},{"key":"R44-20260429","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1111\/liv.14985","article-title":"Drug-induced liver injury at a tertiary care centre in Germany: Model for end-stage liver disease is the best predictor of outcome.","volume":"41","author":"Reike-Kunze","year":"2021","journal-title":"Liver Int"},{"key":"R45-20260429","doi-asserted-by":"crossref","first-page":"e16146","DOI":"10.1111\/liv.16146","article-title":"Epidemiology and risk determinants of drug-induced liver injury: current knowledge and future research needs.","volume":"45","author":"Suzuki","year":"2025","journal-title":"Liver Int"},{"key":"R46-20260429","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S2468-1253(24)00324-8","article-title":"Herbal and dietary supplements: unregulated hepatotoxicity.","volume":"9","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R47-20260429","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/bcp.14254","article-title":"Metamizole: an underrated agent causing severe idiosyncratic drug-induced liver injury.","volume":"86","author":"Sebode","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"R48-20260429","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/liv.12278","article-title":"Drug-induced hepatotoxicity: incidence of abnormal liver function tests consistent with volatile anaesthetic hepatitis in trauma patients.","volume":"34","author":"Lin","year":"2014","journal-title":"Liver Int"},{"key":"R49-20260429","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2147\/TCRM.S248441","article-title":"Comparison of the postoperative liver function between total intravenous anesthesia and inhalation anesthesia in patients with preoperatively elevated liver transaminase levels: a retrospective cohort study.","volume":"16","author":"Oh","year":"2020","journal-title":"Ther Clin Risk Manag"},{"key":"R50-20260429","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.3390\/cimb46040189","article-title":"In vitro hepatotoxicity of routinely used opioids and sedative drugs.","volume":"46","author":"Haller","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"R52-20260429","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature.","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"R53-20260429","doi-asserted-by":"crossref","first-page":"101557","DOI":"10.1016\/j.lanepe.2025.101557","article-title":"Real-world evidence in metabolic dysfunction-associated steatotic liver disease (MASLD): insights, challenges, and future directions.","volume":"62","author":"Huang","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"R54-20260429","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease.","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"key":"R55-20260429","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","article-title":"Steatotic liver disease.","volume":"404","author":"Israelsen","year":"2024","journal-title":"Lancet"},{"key":"R56-20260429","doi-asserted-by":"crossref","first-page":"e00009924","DOI":"10.1590\/0102-311xen009924","article-title":"Comparing diabetes prediction based on metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease: the ELSA-Brasil study.","volume":"40","author":"Lopes","year":"2024","journal-title":"Cad Saude Publica"},{"key":"R57-20260429","doi-asserted-by":"crossref","first-page":"e076388","DOI":"10.1136\/bmj-2023-076388","article-title":"Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study.","volume":"384","author":"Kim","year":"2024","journal-title":"BMJ"},{"key":"R58-20260429","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jhep.2025.03.001","article-title":"Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden.","volume":"83","author":"Issa","year":"2025","journal-title":"J Hepatol"},{"key":"R59-20260429","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1002\/hep4.1772","article-title":"Fatty liver is an independent risk factor for delayed recovery from anesthesia.","volume":"5","author":"Shapses","year":"2021","journal-title":"Hepatol Commun"},{"key":"R60-20260429","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacc.2013.05.045","article-title":"Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome.","volume":"62","author":"Drager","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R61-20260429","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bja.2025.10.006","article-title":"Difficult Airway Society 2025 guidelines for management of unanticipated difficult tracheal intubation in adults.","volume":"136","author":"Ahmad","year":"2026","journal-title":"Br J Anaesth"},{"key":"R62-20260429","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1055\/a-2462-8656","article-title":"Autoimmune and genetic-cholestatic liver diseases: the new guidelines.","volume":"150","author":"Sebode","year":"2025","journal-title":"Dtsch Med Wochenschr"},{"key":"R63-20260429","doi-asserted-by":"crossref","first-page":"33","DOI":"10.21037\/tgh-24-140","article-title":"Overlap syndromes in autoimmune liver disease: a review.","volume":"10","author":"Sohal","year":"2025","journal-title":"Transl Gastroenterol Hepatol"},{"key":"R64-20260429","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5500\/wjt.v12.i3.59","article-title":"Autoimmune hepatitis and liver transplantation: Indications, and recurrent and de novo autoimmune hepatitis.","volume":"12","author":"Harputluoglu","year":"2022","journal-title":"World J Transplant"},{"key":"R65-20260429","doi-asserted-by":"crossref","first-page":"151","DOI":"10.14309\/ajg.0000000000003174","article-title":"Primary biliary cholangitis and primary sclerosing cholangitis therapy landscape.","volume":"120","author":"Bhushan","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"R66-20260429","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJMoa2312100","article-title":"A phase 3 trial of seladelpar in primary biliary cholangitis.","volume":"390","author":"Hirschfield","year":"2024","journal-title":"N Engl J Med"},{"key":"R67-20260429","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2306185","article-title":"Efficacy and safety of elafibranor in primary biliary cholangitis.","volume":"390","author":"Kowdley","year":"2024","journal-title":"N Engl J Med"},{"key":"R68-20260429","doi-asserted-by":"crossref","first-page":"713754","DOI":"10.1155\/2014\/713754","article-title":"Genetic diseases that predispose to early liver cirrhosis.","volume":"2014","author":"Scorza","year":"2014","journal-title":"Int J Hepatol"},{"key":"R69-20260429","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41575-022-00729-0","article-title":"Gene therapy for liver diseases \u2014 progress and challenges.","volume":"20","author":"Zabaleta","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R70-20260429","doi-asserted-by":"crossref","first-page":"2501101","DOI":"10.1183\/13993003.01101-2025","article-title":"A cure for alpha-1? Novel therapeutics in alpha-1 antitrypsin deficiency.","volume":"66","author":"Alluhibi","year":"2025","journal-title":"Eur Respir J"},{"key":"R71-20260429","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1056\/NEJMra1208937","article-title":"Acute liver failure.","volume":"369","author":"Bernal","year":"2013","journal-title":"N Engl J Med"},{"key":"R72-20260429","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1056\/NEJMra1914900","article-title":"Acute-on-chronic liver failure.","volume":"382","author":"Arroyo","year":"2020","journal-title":"N Engl J Med"},{"key":"R73-20260429","first-page":"282","article-title":"The management of fulminant hepatic failure.","volume":"3","author":"Trey","year":"1970","journal-title":"Prog Liver Dis"},{"key":"R74-20260429","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000047017","article-title":"Acute-on-chronic liver failure: pathophysiological basis of therapeutic options.","volume":"20","author":"Jalan","year":"2002","journal-title":"Blood Purif"},{"key":"R75-20260429","first-page":"43","article-title":"The epidemiology of acute liver failure.","volume":"117","author":"Weiler","year":"2020","journal-title":"Dtsch Arztebl Int"},{"key":"R76-20260429","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/hep.23937","article-title":"Drug-induced acute liver failure: results of a U.S. multicenter, prospective study.","volume":"52","author":"Reuben","year":"2010","journal-title":"Hepatology"},{"key":"R77-20260429","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000444915","article-title":"Liver failure due to acute viral hepatitis (A-E).","volume":"32","author":"Manka","year":"2016","journal-title":"Visc Med"},{"key":"R78-20260429","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0140-6736(10)60274-7","article-title":"Acute liver failure.","volume":"376","author":"Bernal","year":"2010","journal-title":"Lancet"},{"key":"R79-20260429","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fphys.2015.00178","article-title":"Two sides of one coin: massive hepatic necrosis and progenitor cell-mediated regeneration in acute liver failure.","volume":"6","author":"Weng","year":"2015","journal-title":"Front Physiol"},{"key":"R80-20260429","doi-asserted-by":"crossref","first-page":"101131","DOI":"10.1016\/j.jhepr.2024.101131","article-title":"Acute liver failure: a practical update.","volume":"6","author":"Fern\u00e1ndez","year":"2024","journal-title":"JHEP Rep"},{"key":"R81-20260429","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1055\/s-0038-1672139","article-title":"Shock etiologies and fluid management in liver failure.","volume":"39","author":"Weiss","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"key":"R82-20260429","first-page":"96","article-title":"Acute-on-chronic liver failure.","volume":"122","author":"Trebicka","year":"2025","journal-title":"Dtsch Arztebl Int"},{"key":"R83-20260429","doi-asserted-by":"crossref","first-page":"100176","DOI":"10.1016\/j.jhepr.2020.100176","article-title":"Acute-on-chronic liver failure: definitions, pathophysiology and principles of treatment.","volume":"3","author":"Zaccherini","year":"2021","journal-title":"JHEP Rep"},{"key":"R84-20260429","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2023.04.021","article-title":"EASL Clinical Practice Guidelines on acute-on-chronic liver failure.","volume":"79","author":"Moreau","year":"2023","journal-title":"J Hepatol"},{"key":"R85-20260429","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-024-10773-4","article-title":"Acute-on-chronic liver failure (ACLF): the \u2018Kyoto Consensus\u2019\u2014steps from Asia.","volume":"19","author":"Choudhury","year":"2025","journal-title":"Hepatol Int"},{"key":"R86-20260429","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-025-01159-4","article-title":"Acute-on-chronic liver failure: pathophysiological mechanisms and clinical management.","author":"Sarin","year":"2026","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R87-20260429","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s13054-018-2156-0","article-title":"Validation of CLIF-C ACLF score to define a threshold for futility of intensive care support for patients with acute-on-chronic liver failure.","volume":"22","author":"Engelmann","year":"2018","journal-title":"Crit Care"},{"key":"R88-20260429","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jceh.2022.03.004","article-title":"Surgical risk assessment in patients with chronic liver diseases.","volume":"12","author":"Jadaun","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"R89-20260429","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cgh.2018.09.043","article-title":"AGA clinical practice update on surgical risk assessment and perioperative management in cirrhosis: expert review.","volume":"17","author":"Northup","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R90-20260429","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/bja\/aew316","article-title":"Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries.","volume":"117","year":"2016","journal-title":"Br J Anaesth"},{"key":"R91-20260429","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bja.2021.11.011","article-title":"Death after surgery among patients with chronic disease: prospective study of routinely collected data in the English NHS.","volume":"128","author":"Fowler","year":"2022","journal-title":"Br J Anaesth"},{"key":"R92-20260429","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00268-011-1007-9","article-title":"Inguinal hernia repair in patients with cirrhosis is not associated with increased risk of complications and recurrence.","volume":"35","author":"Oh","year":"2011","journal-title":"World J Surg"},{"key":"R93-20260429","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3138\/canlivj-2024-0015","article-title":"Higher pre-operative non-invasive fibrosis scores are not associated with surgical outcomes in patients with MASLD undergoing metabolic and bariatric surgery.","volume":"8","author":"Huynh","year":"2025","journal-title":"Can Liver J"},{"key":"R94-20260429","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.surg.2011.02.026","article-title":"A prospective study on elective umbilical hernia repair in patients with liver cirrhosis and ascites.","volume":"150","author":"Eker","year":"2011","journal-title":"Surgery"},{"key":"R95-20260429","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s10120-016-0675-4","article-title":"Comparison of long-term survival and immediate postoperative liver function after laparoscopic and open distal gastrectomy for early gastric cancer patients with liver cirrhosis.","volume":"20","author":"Alshahrani","year":"2017","journal-title":"Gastric Cancer"},{"key":"R96-20260429","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jhep.2025.04.008","article-title":"EASL Clinical Practice Guidelines on extrahepatic abdominal surgery in patients with cirrhosis and advanced chronic liver disease.","volume":"83","author":"Thabut","year":"2025","journal-title":"J Hepatol"},{"key":"R97-20260429","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1186\/s12876-025-04482-x","article-title":"Impact of metabolic and bariatric surgery on MASLD: histological resolution and metabolic outcomes in a retrospective cohort.","volume":"25","author":"Longsomboon","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"R98-20260429","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1007\/s11695-025-08274-w","article-title":"Efficacy of roux-en-y gastric bypass and sleeve gastrectomy on hepatic steatosis and fibrosis markers: a meta-analysis of randomized clinical trials.","volume":"35","author":"Pereira","year":"2025","journal-title":"Obes Surg"},{"key":"R99-20260429","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jss.2016.11.013","article-title":"Emergent laparotomy and temporary abdominal closure for the cirrhotic patient.","volume":"210","author":"Loftus","year":"2017","journal-title":"J Surg Res"},{"key":"R100-20260429","doi-asserted-by":"crossref","first-page":"783823","DOI":"10.1155\/2015\/783823","article-title":"Cholecystectomy in patients with liver cirrhosis.","volume":"2015","author":"Stromberg","year":"2015","journal-title":"Gastroenterol Res Pract"},{"key":"R101-20260429","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/icvts\/ivx132","article-title":"Can oesophagectomy be performed for patients with oesophageal carcinoma and concomitant liver cirrhosis? A retrospective study based on a propensity-matched cohort.","volume":"25","author":"Wang","year":"2017","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R102-20260429","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1245\/s10434-016-5610-8","article-title":"Esophageal cancer surgery for patients with concomitant liver cirrhosis: a single-center matched-cohort study.","volume":"24","author":"Valmasoni","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R103-20260429","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/anae.16559","article-title":"Outcomes of after-hours surgeries performed under general anaesthesia: a South Korean nationwide cohort study.","volume":"80","author":"Oh","year":"2025","journal-title":"Anaesthesia"},{"key":"R104-20260429","first-page":"192","article-title":"Surgery in the patient with liver disease.","volume":"121","author":"Friedman","year":"2010","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"R105-20260429","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1007\/s00464-017-5806-4","article-title":"Laparoscopic colectomy reduces complications and hospital length of stay in colon cancer patients with liver disease and ascites.","volume":"32","author":"Pei","year":"2018","journal-title":"Surg Endosc"},{"key":"R106-20260429","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/cld.546","article-title":"Risk stratification and preoperative evaluation of the patient with known or suspected liver disease.","volume":"7","author":"Prenner","year":"2016","journal-title":"Clin Liver Dis"},{"key":"R107-20260429","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.21563","article-title":"The model for end-stage liver disease (MELD).","volume":"45","author":"Kamath","year":"2007","journal-title":"Hepatology"},{"key":"R108-20260429","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/he.2000.5852","article-title":"A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.","volume":"31","author":"Malinchoc","year":"2000","journal-title":"Hepatology"},{"key":"R109-20260429","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1053\/j.gastro.2007.01.040","article-title":"Risk factors for mortality after surgery in patients with cirrhosis.","volume":"132","author":"Teh","year":"2007","journal-title":"Gastroenterology"},{"key":"R110-20260429","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.31558","article-title":"Risk prediction models for post-operative mortality in patients with cirrhosis.","volume":"73","author":"Mahmud","year":"2021","journal-title":"Hepatology"},{"key":"R111-20260429","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11605-010-1366-9","article-title":"Perioperative mortality after non-hepatic general surgery in patients with liver cirrhosis: an analysis of 138 operations in the 2000s using Child and MELD scores.","volume":"15","author":"Neeff","year":"2011","journal-title":"J Gastrointest Surg"},{"key":"R112-20260429","doi-asserted-by":"crossref","first-page":"20210061","DOI":"10.1259\/bjr.20210061","article-title":"Hepatic venous-portal gradient (HVPG) measurement: pearls and pitfalls.","volume":"94","author":"Lu","year":"2021","journal-title":"Br J Radiol"},{"key":"R113-20260429","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1177\/00031348211069784","article-title":"Perioperative transjugular intrahepatic portosystemic shunt is associated with decreased postoperative complications in decompensated cirrhotics undergoing abdominal surgery.","volume":"88","author":"Aryan","year":"2022","journal-title":"Am Surg"},{"key":"R114-20260429","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMra2215289","article-title":"Acute kidney injury in patients with cirrhosis.","volume":"388","author":"Nadim","year":"2023","journal-title":"N Engl J Med"},{"key":"R115-20260429","doi-asserted-by":"crossref","first-page":"e14475","DOI":"10.1097\/MD.0000000000014475","article-title":"Renal impairment is associated with increased risk of mortality in patients with cirrhosis: a retrospective cohort study.","volume":"98","author":"Umemura","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R116-20260429","first-page":"e94298","article-title":"The impact of preoperative hepatic impairment on the development of postoperative delirium: a systematic review and meta-analysis.","volume":"17","author":"Roberts","year":"2025","journal-title":"Cureus"},{"key":"R117-20260429","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2022.06.001","article-title":"EASL Clinical Practice Guidelines on the management of hepatic encephalopathy.","volume":"77","author":"Montagnese","year":"2022","journal-title":"J Hepatol"},{"key":"R118-20260429","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/hep.30534","article-title":"Prognostic role of ammonia in patients with cirrhosis.","volume":"70","author":"Shalimar","year":"2019","journal-title":"Hepatology"},{"key":"R119-20260429","doi-asserted-by":"crossref","first-page":"723","DOI":"10.14309\/ajg.0000000000000343","article-title":"Ammonia levels do not guide clinical management of patients with hepatic encephalopathy caused by cirrhosis.","volume":"115","author":"Haj","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"R120-20260429","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.29146","article-title":"The animal naming test: an easy tool for the assessment of hepatic encephalopathy.","volume":"66","author":"Campagna","year":"2017","journal-title":"Hepatology"},{"key":"R121-20260429","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/jth.15239","article-title":"The concept of rebalanced hemostasis in patients with liver disease: communication from the ISTH SSC working group on hemostatic management of patients with liver disease.","volume":"19","author":"Lisman","year":"2021","journal-title":"J Thromb Haemost"},{"key":"R122-20260429","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease.","volume":"365","author":"Tripodi","year":"2011","journal-title":"N Engl J Med"},{"key":"R123-20260429","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jhep.2021.09.003","article-title":"EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis.","volume":"76","author":"Villa","year":"2022","journal-title":"J Hepatol"},{"key":"R124-20260429","doi-asserted-by":"crossref","first-page":"e2225","DOI":"10.1097\/MD.0000000000002225","article-title":"Hemorrhagic complications following abdominal paracentesis in acute on chronic liver failure: a propensity score analysis.","volume":"94","author":"Lin","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R125-20260429","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2018.11.019","article-title":"Use of prothrombin complex concentrates in patients with decompensated liver cirrhosis is associated with thromboembolic events.","volume":"70","author":"Tischendorf","year":"2019","journal-title":"J Hepatol"},{"key":"R126-20260429","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/MCG.0000000000001285","article-title":"Thromboelastography better reflects hemostatic abnormalities in cirrhotics compared with the international normalized ratio.","volume":"54","author":"Hum","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"R127-20260429","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/jth.13957","article-title":"Measuring fibrinolysis: from research to routine diagnostic assays.","volume":"16","author":"Longstaff","year":"2018","journal-title":"J Thromb Haemost"},{"key":"R128-20260429","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/MCG.0000000000001327","article-title":"Interpreting hemostatic profiles assessed with viscoelastic tests in patients with cirrhosis.","volume":"54","author":"Lisman","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"R129-20260429","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1478-3231.2009.02135.x","article-title":"Nutritional status: its influence on the outcome of patients undergoing liver transplantation.","volume":"30","author":"Merli","year":"2010","journal-title":"Liver Int"},{"key":"R130-20260429","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0899-9007(02)00984-X","article-title":"Malnutrition is a risk factor in cirrhotic patients undergoing surgery.","volume":"18","author":"Merli","year":"2002","journal-title":"Nutrition"},{"key":"R131-20260429","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1097\/CCM.0000000000004192","article-title":"Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU: cardiovascular, endocrine, hematologic, pulmonary, and renal considerations.","volume":"48","author":"Nanchal","year":"2020","journal-title":"Crit Care Med"},{"key":"R132-20260429","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/CCM.0000000000005824","article-title":"Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU: neurology, peri-transplant medicine, infectious disease, and gastroenterology considerations.","volume":"51","author":"Nanchal","year":"2023","journal-title":"Crit Care Med"},{"key":"R133-20260429","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jhep.2023.02.024","article-title":"Fluid resuscitation in patients with cirrhosis and sepsis: a multidisciplinary perspective.","volume":"79","author":"Durand","year":"2023","journal-title":"J Hepatol"},{"key":"R134-20260429","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0168-8278(01)00200-8","article-title":"Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusions.","volume":"35","author":"Christidis","year":"2001","journal-title":"J Hepatol"},{"key":"R135-20260429","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.transproceed.2015.05.015","article-title":"Impact of 6% starch 130\/0.4 and 4% gelatin infusion on kidney function in living-donor liver transplantation.","volume":"47","author":"Demir","year":"2015","journal-title":"Transplant Proc"},{"key":"R136-20260429","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00134-024-07369-9","article-title":"Part 1: the choice of resuscitation fluids.","volume":"50","author":"Arabi","year":"2024","journal-title":"Intensive Care Med"},{"key":"R137-20260429","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4254\/wjh.v8.i7.345","article-title":"Human albumin solution for patients with cirrhosis and acute on chronic liver failure: beyond simple volume expansion.","volume":"8","author":"Valerio","year":"2016","journal-title":"World J Hepatol"},{"key":"R138-20260429","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1007\/s12072-022-10374-z","article-title":"Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials.","volume":"16","author":"Bai","year":"2022","journal-title":"Hepatol Int"},{"key":"R139-20260429","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jhep.2023.04.006","article-title":"A randomised-controlled trial (TARGET-C) of high vs. low target mean arterial pressure in patients with cirrhosis and septic shock.","volume":"79","author":"Maiwall","year":"2023","journal-title":"J Hepatol"},{"key":"R140-20260429","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.4528","article-title":"Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis.","volume":"319","author":"McIntyre","year":"2018","journal-title":"JAMA"},{"key":"R141-20260429","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2036.2007.03369.x","article-title":"Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease.","volume":"26","author":"Tripodi","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R142-20260429","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/MCG.0000000000001214","article-title":"Thromboelastography-guided blood product transfusion in cirrhosis patients with variceal bleeding: a randomized controlled trial.","volume":"54","author":"Rout","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"R143-20260429","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/hep.30794","article-title":"Thromboelastography-guided blood component use in patients with cirrhosis with nonvariceal bleeding: a randomized controlled trial.","volume":"71","author":"Kumar","year":"2020","journal-title":"Hepatology"},{"key":"R144-20260429","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/hep.28148","article-title":"Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial.","volume":"63","author":"De Pietri","year":"2016","journal-title":"Hepatology"},{"key":"R145-20260429","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1211801","article-title":"Transfusion strategies for acute upper gastrointestinal bleeding.","volume":"368","author":"Villanueva","year":"2013","journal-title":"N Engl J Med"},{"key":"R146-20260429","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/jgh3.12255","article-title":"Enteric tube placement in patients with esophageal varices: risks and predictors of postinsertion gastrointestinal bleeding.","volume":"4","author":"Al-Obaid","year":"2020","journal-title":"JGH Open"},{"key":"R147-20260429","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.bja.2019.08.017","article-title":"Lung-protective ventilation for the surgical patient: international expert panel-based consensus recommendations.","volume":"123","author":"Young","year":"2019","journal-title":"Br J Anaesth"},{"key":"R149-20260429","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome.","volume":"384","author":"Wong","year":"2021","journal-title":"N Engl J Med"},{"key":"R150-20260429","first-page":"e91035","article-title":"Regional anesthesia in a cirrhotic patient with coagulopathy and pulmonary hypertension: a case report.","volume":"17","author":"Lu","year":"2025","journal-title":"Cureus"},{"key":"R151-20260429","first-page":"e80433","article-title":"Ultrasound-guided rectus sheath block with monitored anesthesia care for necrotic umbilical hernia repair in a patient with severe liver failure and refractory ascites: a case report.","volume":"17","author":"Nakazawa","year":"2025","journal-title":"Cureus"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000001648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:07:20Z","timestamp":1777457240000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000001648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":149,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0000000000001648","relation":{},"ISSN":["0952-7907","1473-6500"],"issn-type":[{"value":"0952-7907","type":"print"},{"value":"1473-6500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]}}}